Scheme target in multiple myeloma. Appl ID 1050067. Priority Driven Collaborative Priority-driven Cancer Research Scheme Collaborative (PDCCRS) 2012: Equivalence Cancer The Australian Cancer of sun exposure and vitamin $582,911 01/03/2013 58 Acton 200 Australia National University Research D supplementation in vitamin Scheme D insufficiency. Appl ID 1045198 Priority Driven Collaborative Priority-driven Cancer Research Scheme Collaborative Walter and Eliza Cancer (PDCCRS) 2012: Innate Cancer Hall Institute of $26,826.53 01/03/2013 12 Parkville 3052 Australia immune cell protection and Research Medical Research colon cancer. Appl ID Scheme 1050241 Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2012: PETACC-6: Priority-driven Preoperative Collaborative chemoradiotherapy and Cancer University of The University of Cancer postoperative chemotherapy $123,331 04/03/2013 49 2006 Australia Sydney Sydney Research with capecitabine and Scheme oxaliplatin vs. capecitabine alone in locally advanced rectal cancer. Appl ID 1048035 Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2012: Production of Priority-driven Off The Shelf T-cells Expressing Collaborative a Non-MHC Restricted CD19 Cancer University of Cancer Specific Chimeric Antigen $47,500 04/03/2013 37 University of Sydney 2006 Australia Sydney Research Receptor for use in a Phase I Scheme Study of T-cell Therapy of Relapsed and Refractory Bcell Malignancies (UNI-T Study). Appl ID 1047454 Priority Driven Collaborative Cancer Research Scheme Priority-driven (PDCCRS) 2012: Investigating Collaborative Cancer University of the mechanism of action of Cancer $24,972.75 04/03/2013 12 University of Sydney 2006 Australia Sydney the cancer-associated Research enzyme telomerase using Scheme disease linked telomerase mutants. Appl ID 1048376
Scheme target in multiple myeloma. Appl ID 1050067. Cancer Australia Priority-driven Collaborative Cancer Research Scheme The Australian National University Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2012: Equivalence of sun exposure and vitamin D supplementation in vitamin D insufficiency. Appl ID 1045198 $582,911 01/03/2013 58 Acton 200 Cancer Australia Priority-driven Collaborative Cancer Research Scheme Walter and Eliza Hall Institute of Medical Research Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2012: Innate immune cell protection and colon cancer. Appl ID 1050241 $26,826.53 01/03/2013 12 Parkville 3052 Cancer Australia Priority-driven Collaborative Cancer Research Scheme University of Sydney Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2012: PETACC-6: Preoperative chemoradiotherapy and postoperative chemotherapy with capecitabine and oxaliplatin vs. capecitabine alone in locally advanced rectal cancer. Appl ID 1048035 $123,331 04/03/2013 49 The University of Sydney 2006 Cancer Australia Priority-driven Collaborative Cancer Research Scheme University of Sydney Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2012: Production of Off The Shelf T-cells Expressing a Non-MHC Restricted CD19 Specific Chimeric Antigen Receptor for use in a Phase I Study of T-cell Therapy of Relapsed and Refractory Bcell Malignancies (UNI-T Study). Appl ID 1047454 $47,500 04/03/2013 37 University of Sydney 2006 Cancer Australia Priority-driven Collaborative Cancer Research Scheme University of Sydney Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2012: Investigating the mechanism of action of the cancer-associated enzyme telomerase using disease linked telomerase mutants. Appl ID 1048376 $24,972.75 04/03/2013 12 University of Sydney 2006
grants_reporting_20170703.docx